<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003121'>Genomic imprinting</z:mp>, or parental allele-specific expression of genes, has been demonstrated at the molecular level in insects and mice but not in man </plain></SENT>
<SENT sid="1" pm="."><plain>Imprinting as a potential mechanism of human disease is suggested by paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> of 11p15 in <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and by maternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> of 15q11-12 in Prader-Willi syndrome </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> is characterized by multiorgan <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and predisposition to <z:e sem="disease" ids="C0027654" disease_type="Neoplastic Process" abbrv="">embryonal tumours</z:e> such as <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour of the kidney</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A loss of heterozygosity of 11p15 is also frequently found in a wide variety of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, including <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> and lung, bladder, ovarian, liver and <z:hpo ids='HP_0003002'>breast cancers</z:hpo>; 11p15 also directly suppresses <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>Two genes in this band, H19 and insulin-like growth factor-II (IGF2) undergo reciprocal imprinting in the mouse, with maternal expression of H19 (ref </plain></SENT>
<SENT sid="5" pm="."><plain>13) and paternal expression of IGF2 (ref </plain></SENT>
<SENT sid="6" pm="."><plain>14) </plain></SENT>
<SENT sid="7" pm="."><plain>Here we find that both of these genes show monoallelic expression in human tissues and, as in mouse, H19 is expressed from the maternal allele and IGF2 from the paternal allele </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, 69% of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumours</z:e> not undergoing loss of heterozygosity at 11p showed biallelic expression of one or both genes, suggesting that relaxation or loss of imprinting could represent a new epigenetic mutational mechanism in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>